Call Options

16 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 15, 2024

SELL
$19.09 - $22.57 $429,525 - $507,825
-22,500 Reduced 59.68%
15,200 $298,000
Q1 2024

May 07, 2024

SELL
$21.55 - $29.29 $454,705 - $618,019
-21,100 Reduced 35.88%
37,700 $818,000
Q4 2023

Feb 14, 2024

SELL
$23.64 - $30.27 $5.45 Million - $6.98 Million
-230,700 Reduced 79.69%
58,800 $1.7 Million
Q3 2023

Nov 14, 2023

BUY
$26.74 - $40.81 $6.65 Million - $10.1 Million
248,600 Added 607.82%
289,500 $7.74 Million
Q2 2023

Aug 11, 2023

SELL
$28.52 - $40.7 $1.06 Million - $1.51 Million
-37,200 Reduced 47.63%
40,900 $1.51 Million
Q1 2023

May 16, 2023

SELL
$29.39 - $36.27 $1.16 Million - $1.43 Million
-39,300 Reduced 33.48%
78,100 $2.44 Million
Q4 2022

Feb 14, 2023

SELL
$29.23 - $40.28 $1.51 Million - $2.08 Million
-51,600 Reduced 30.53%
117,400 $3.5 Million
Q3 2022

Nov 14, 2022

SELL
$37.92 - $63.74 $6.63 Million - $11.1 Million
-174,900 Reduced 50.86%
169,000 $6.44 Million
Q2 2022

Aug 15, 2022

BUY
$47.98 - $62.75 $4.88 Million - $6.39 Million
101,800 Added 42.05%
343,900 $18.8 Million
Q1 2022

May 16, 2022

BUY
$49.85 - $96.11 $4.6 Million - $8.87 Million
92,300 Added 61.62%
242,100 $15.1 Million
Q4 2021

Feb 14, 2022

SELL
$77.3 - $105.0 $8.19 Million - $11.1 Million
-106,000 Reduced 41.44%
149,800 $15.1 Million
Q3 2021

Nov 15, 2021

SELL
$74.87 - $110.87 $2.88 Million - $4.26 Million
-38,400 Reduced 13.05%
255,800 $23 Million
Q2 2021

Aug 11, 2021

BUY
$66.8 - $100.45 $2.13 Million - $3.2 Million
31,900 Added 12.16%
294,200 $27.1 Million
Q1 2021

May 17, 2021

BUY
$59.3 - $183.85 $9.01 Million - $27.9 Million
152,000 Added 137.81%
262,300 $25.3 Million
Q4 2020

Feb 16, 2021

BUY
$31.01 - $52.1 $889,987 - $1.5 Million
28,700 Added 35.17%
110,300 $5.75 Million
Q3 2020

Nov 16, 2020

BUY
$15.89 - $50.51 $1.3 Million - $4.12 Million
81,600 New
81,600 $3.27 Million

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $524M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.